Cargando…

Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner

BACKGROUND: Inadequate coronary adenosine response is a potential cause for false negative ischemia testing. Recently, the splenic switch-off (SSO) sign has been identified as a promising tool to ascertain the efficacy of adenosine during vasodilator stress cardiovascular magnetic resonance imaging...

Descripción completa

Detalles Bibliográficos
Autores principales: Patriki, Dimitri, von Felten, Elia, Bakula, Adam, Giannopoulos, Andreas A., Kamani, Christel H., Schwyzer, Moritz, Messerli, Michael, Benz, Dominik C., Gebhard, Catherine, Gräni, Christoph, Pazhenkottil, Aju P., Kaufmann, Philipp A., Fuchs, Tobias A., Buechel, Ronny R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789581/
https://www.ncbi.nlm.nih.gov/pubmed/33407586
http://dx.doi.org/10.1186/s12968-020-00696-y
_version_ 1783633271047847936
author Patriki, Dimitri
von Felten, Elia
Bakula, Adam
Giannopoulos, Andreas A.
Kamani, Christel H.
Schwyzer, Moritz
Messerli, Michael
Benz, Dominik C.
Gebhard, Catherine
Gräni, Christoph
Pazhenkottil, Aju P.
Kaufmann, Philipp A.
Fuchs, Tobias A.
Buechel, Ronny R.
author_facet Patriki, Dimitri
von Felten, Elia
Bakula, Adam
Giannopoulos, Andreas A.
Kamani, Christel H.
Schwyzer, Moritz
Messerli, Michael
Benz, Dominik C.
Gebhard, Catherine
Gräni, Christoph
Pazhenkottil, Aju P.
Kaufmann, Philipp A.
Fuchs, Tobias A.
Buechel, Ronny R.
author_sort Patriki, Dimitri
collection PubMed
description BACKGROUND: Inadequate coronary adenosine response is a potential cause for false negative ischemia testing. Recently, the splenic switch-off (SSO) sign has been identified as a promising tool to ascertain the efficacy of adenosine during vasodilator stress cardiovascular magnetic resonance imaging (CMR). We assessed the value of SSO to predict adenosine response, defined as an increase in myocardial blood flow (MBF) during quantitative stress myocardial perfusion 13 N-ammonia positron emission tomography (PET). METHODS: We prospectively enrolled 64 patients who underwent simultaneous CMR and PET myocardial perfusion imaging on a hybrid PET/CMR scanner with co-injection of gadolinium based contrast agent (GBCA) and 13N-ammonia during rest and adenosine-induced stress. A myocardial flow reserve (MFR) of  > 1.5 or ischemia as assessed by PET were defined as markers for adequate coronary adenosine response. The presence or absence of SSO was visually assessed. The stress-to-rest intensity ratio (SIR) was calculated as the ratio of stress over rest peak signal intensity for splenic tissue. Additionally, the spleen-to-myocardium ratio, defined as the relative change of spleen to myocardial signal, was calculated for stress (SMR(stress)) and rest. RESULTS: Sixty-one (95%) patients were coronary adenosine responders, but SSO was absent in 18 (28%) patients. SIR and SMR(stress) were significantly lower in patients with SSO (SIR: 0.56 ± 0.13 vs. 0.93 ± 0.23; p < 0.001 and SMR(stress): 1.09 ± 0.47 vs. 1.68 ± 0.62; p < 0.001). Mean hyperemic and rest MBF were 2.12 ± 0.68 ml/min/g and 0.78 ± 0.26 ml/min/g, respectively. MFR was significantly higher in patients with vs. patients without presence of SSO (3.07 ± 1.03 vs. 2.48 ± 0.96; p = 0.038), but there was only a weak inverse correlation between SMR(stress) and MFR (R = -0.378; p = 0.02) as well as between SIR and MFR (R = -0.356; p = 0.004). CONCLUSIONS: The presence of SSO implies adequate coronary adenosine-induced MBF response. Its absence, however, is not a reliable indicator for failed adenosine-induced coronary vasodilatation.
format Online
Article
Text
id pubmed-7789581
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77895812021-01-07 Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner Patriki, Dimitri von Felten, Elia Bakula, Adam Giannopoulos, Andreas A. Kamani, Christel H. Schwyzer, Moritz Messerli, Michael Benz, Dominik C. Gebhard, Catherine Gräni, Christoph Pazhenkottil, Aju P. Kaufmann, Philipp A. Fuchs, Tobias A. Buechel, Ronny R. J Cardiovasc Magn Reson Research BACKGROUND: Inadequate coronary adenosine response is a potential cause for false negative ischemia testing. Recently, the splenic switch-off (SSO) sign has been identified as a promising tool to ascertain the efficacy of adenosine during vasodilator stress cardiovascular magnetic resonance imaging (CMR). We assessed the value of SSO to predict adenosine response, defined as an increase in myocardial blood flow (MBF) during quantitative stress myocardial perfusion 13 N-ammonia positron emission tomography (PET). METHODS: We prospectively enrolled 64 patients who underwent simultaneous CMR and PET myocardial perfusion imaging on a hybrid PET/CMR scanner with co-injection of gadolinium based contrast agent (GBCA) and 13N-ammonia during rest and adenosine-induced stress. A myocardial flow reserve (MFR) of  > 1.5 or ischemia as assessed by PET were defined as markers for adequate coronary adenosine response. The presence or absence of SSO was visually assessed. The stress-to-rest intensity ratio (SIR) was calculated as the ratio of stress over rest peak signal intensity for splenic tissue. Additionally, the spleen-to-myocardium ratio, defined as the relative change of spleen to myocardial signal, was calculated for stress (SMR(stress)) and rest. RESULTS: Sixty-one (95%) patients were coronary adenosine responders, but SSO was absent in 18 (28%) patients. SIR and SMR(stress) were significantly lower in patients with SSO (SIR: 0.56 ± 0.13 vs. 0.93 ± 0.23; p < 0.001 and SMR(stress): 1.09 ± 0.47 vs. 1.68 ± 0.62; p < 0.001). Mean hyperemic and rest MBF were 2.12 ± 0.68 ml/min/g and 0.78 ± 0.26 ml/min/g, respectively. MFR was significantly higher in patients with vs. patients without presence of SSO (3.07 ± 1.03 vs. 2.48 ± 0.96; p = 0.038), but there was only a weak inverse correlation between SMR(stress) and MFR (R = -0.378; p = 0.02) as well as between SIR and MFR (R = -0.356; p = 0.004). CONCLUSIONS: The presence of SSO implies adequate coronary adenosine-induced MBF response. Its absence, however, is not a reliable indicator for failed adenosine-induced coronary vasodilatation. BioMed Central 2021-01-07 /pmc/articles/PMC7789581/ /pubmed/33407586 http://dx.doi.org/10.1186/s12968-020-00696-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Patriki, Dimitri
von Felten, Elia
Bakula, Adam
Giannopoulos, Andreas A.
Kamani, Christel H.
Schwyzer, Moritz
Messerli, Michael
Benz, Dominik C.
Gebhard, Catherine
Gräni, Christoph
Pazhenkottil, Aju P.
Kaufmann, Philipp A.
Fuchs, Tobias A.
Buechel, Ronny R.
Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner
title Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner
title_full Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner
title_fullStr Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner
title_full_unstemmed Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner
title_short Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner
title_sort splenic switch-off as a predictor for coronary adenosine response: validation against 13n-ammonia during co-injection myocardial perfusion imaging on a hybrid pet/cmr scanner
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789581/
https://www.ncbi.nlm.nih.gov/pubmed/33407586
http://dx.doi.org/10.1186/s12968-020-00696-y
work_keys_str_mv AT patrikidimitri splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT vonfeltenelia splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT bakulaadam splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT giannopoulosandreasa splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT kamanichristelh splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT schwyzermoritz splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT messerlimichael splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT benzdominikc splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT gebhardcatherine splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT granichristoph splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT pazhenkottilajup splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT kaufmannphilippa splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT fuchstobiasa splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner
AT buechelronnyr splenicswitchoffasapredictorforcoronaryadenosineresponsevalidationagainst13nammoniaduringcoinjectionmyocardialperfusionimagingonahybridpetcmrscanner